Evidence map›Paper›PMID 35242496›Full record

ReviewAnalytical cellular pathology (Amsterdam)2022

Analysis of the Clinicopathologic Characteristics and Prognosis of Head and Neck Lymphoma.

Shufang Yan, Jiajia Ma, Meihong Yang, Bo Liu, Sijing Li, Liuqing Yang, Qian Zhang, Xinxia Li

Open access · goldAbstract readReview
In one paragraph

Review in Analytical cellular pathology (Amsterdam), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. [Case of concurrent second branchial cleft cyst and diffuse large B-cell lymphoma].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2026
    Article
  2. [A deep learning method for differentiating nasopharyngeal carcinoma and lymphoma based on MRI].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Intraosseous Non-Hodgkin Lymphoma Mimicking a Periapical Lesion.Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shufang YanDepartment of Pathology, The Tumor Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou Dongjie, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, China.ORCID https://orcid.org/0000-0003-4408-0535
Jiajia MaDepartment of Pathology, The Tumor Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou Dongjie, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, China.ORCID https://orcid.org/0000-0001-8678-2979
Meihong YangDepartment of Pathology, The Tumor Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou Dongjie, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, China.ORCID https://orcid.org/0000-0002-0332-9739
Bo LiuDepartment of Pathology, The Tumor Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou Dongjie, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, China.ORCID https://orcid.org/0000-0002-3016-2049
Sijing LiDepartment of Pathology, The Tumor Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou Dongjie, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, China.ORCID https://orcid.org/0000-0002-4354-7167
Liuqing YangDepartment of Pathology, The Tumor Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou Dongjie, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, China.ORCID https://orcid.org/0000-0003-2844-903X
Qian ZhangDepartment of Pathology, The Tumor Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou Dongjie, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, China.ORCID https://orcid.org/0000-0003-3769-2912
Xinxia LiDepartment of Pathology, The Tumor Hospital Affiliated to Xinjiang Medical University, No. 789 Suzhou Dongjie, Urumqi, The Xinjiang Uygur Autonomous Region of China, 830011, China.ORCID https://orcid.org/0000-0002-0742-8072
Xinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Statistical reports on non-Hodgkin's lymphoma (NHL) of the head and neck combining clinical medicine with pathology are rare. To provide a basis for prognosis prediction and individualized treatment, we will investigate the clinicopathologic characteristics and prognosis of lymphoma in the head and neck region. Four hundred sixty-one patients with NHL in the head and neck region diagnosed through histological biopsy were retrospectively analyzed. Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) were performed in all cases to evaluate the genetic status and protein expression levels. Patients were followed up by telephone. The prevalence rate of primary extranodal NHL (PENHL) in the head and neck region was 44.62% (166/372). The incidence of extranodal lymphoma accounted for 36.66% (169/461) of all head and neck lymphomas. Among the cases of PENHL of the head and neck, diffuse large B-cell lymphoma (DLBCL) (60/76, 78.95%) and extranodal NK/T-cell lymphoma, nasal type (ENKTCL) (21/24, 87.5%) were the most common subtypes originating from B-cell lymphoma (BCL) and T-cell lymphoma (TCL), respectively. The most common sites of nodal and extranodal onset were neck lymph nodes and the gastrointestinal tract, respectively. The most common and primary locations of BCL and TCL were the tonsils and nasal cavity, respectively. The 3-year survival rates of PENHL, ENKTCL, and DLBCL of the head and neck were 42%, 28.57%, and 41.67%, respectively, and the 5-year survival rates were 24%, 19.05%, and 20%, respectively. Survival analysis showed that male sex was a risk factor (HR = 5.421; 95% CI, 1.164-25.267;

Indexed as

Lymphoma, Large B-Cell, DiffuseLymphoma, Non-HodgkinHumansIn Situ Hybridization, FluorescenceMaleRetrospective StudiesSurvival Analysis

Identifiers

PMID35242496
PMCPMC8888118
OpenAlexW4213148554

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.